Bellevue Group AG Has $44.39 Million Position in UnitedHealth Group Incorporated $UNH

Bellevue Group AG trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 142,296 shares of the healthcare conglomerate’s stock after selling 22,446 shares during the period. UnitedHealth Group comprises approximately 1.0% of Bellevue Group AG’s portfolio, making the stock its 25th biggest holding. Bellevue Group AG’s holdings in UnitedHealth Group were worth $44,392,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Brighton Jones LLC raised its holdings in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC lifted its position in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the last quarter. Vestmark Advisory Solutions Inc. increased its holdings in shares of UnitedHealth Group by 67.0% during the 1st quarter. Vestmark Advisory Solutions Inc. now owns 12,161 shares of the healthcare conglomerate’s stock valued at $6,369,000 after acquiring an additional 4,877 shares during the last quarter. Horizon Investments LLC lifted its holdings in UnitedHealth Group by 8.6% in the 1st quarter. Horizon Investments LLC now owns 11,462 shares of the healthcare conglomerate’s stock worth $6,003,000 after purchasing an additional 908 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in UnitedHealth Group by 19.3% during the first quarter. Dimensional Fund Advisors LP now owns 5,197,427 shares of the healthcare conglomerate’s stock valued at $2,721,912,000 after purchasing an additional 839,002 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on UNH shares. The Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a report on Tuesday, October 14th. They set a “buy” rating and a $406.00 price objective for the company. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Barclays boosted their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Jefferies Financial Group lifted their price target on UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research report on Friday, October 17th. Finally, Mizuho raised their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Seventeen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Hold” and a consensus price target of $385.54.

UnitedHealth Group Stock Up 1.5%

Shares of UNH stock opened at $341.83 on Friday. The stock has a market cap of $309.65 billion, a P/E ratio of 17.84, a price-to-earnings-growth ratio of 2.20 and a beta of 0.43. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. The stock has a fifty day moving average price of $339.84 and a 200 day moving average price of $316.91. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $606.36.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. During the same period last year, the firm earned $7.15 EPS. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.